ΔΎΉΟΦ±²₯

Meeting Coverage

ASTRO

American Society for Radiation Oncology

'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma

Small study suggests large benefit for Lu-177 dotatate in intracranial disease

ASTRO over a photo of Walter E. Washington Convention Center in Washington, DC.

Latest ASTRO Meeting Coverage

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

Latest negative results emphasize "critical" aspect of immunotherapy timing

October 2, 2024
De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer

With 98% PFS at 2 years, standard RT plus cisplatin sets a higher bar for de-escalation

October 2, 2024
More Evidence Favors a Shorter Course of Post-Mastectomy RT

Trial finds similar complication and recurrence rates with hypofractionated versus standard RT

October 1, 2024
No Improvement in Lymphedema With Hypofractionated Nodal RT for Breast Cancer

Numerical advantage in randomized trial, non-randomized study misses noninferiority mark

October 1, 2024
Neurocognitive Side Effects of Brain Radiation Subside for Many, Analysis Shows

In three trials, about 40% of patients with brain metastases recovered neurocognitive function

October 1, 2024
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

"It really shows us that we have two great options," expert says

September 30, 2024
Can ctDNA Guide Radiation Use in Oligometastatic NSCLC?

Detectable circulating tumor DNA before radiotherapy linked with worse survival

October 5, 2023
Use of Recent Diagnostic CT Scans for Palliative RT Planning Reduced Treatment Time

Time to treatment completion slashed by over 4 hours compared with CT simulation planning

October 4, 2023
Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RT

Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says

October 4, 2023
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer

Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks

October 3, 2023
Sexual Activity Lowers Risk of Side Effects After Cervical Cancer Treatment

Intercourse and/or vaginal dilation reduces risk of vaginal stenosis

October 3, 2023
SABR Offers New Hope for Older Patients With Inoperable Kidney Cancer

Phase II study shows 100% local control and cancer-specific survival after more than 3 years

October 1, 2023
Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormones

Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone

October 27, 2022
Ablative MR-Guided RT Shows Promise in Pancreatic Cancer

SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data

October 27, 2022